Banson Pharmaceuticals Private Limited

Banson Pharmaceuticals Private Limited - pharma in Punjab, India. FY 2026 financials & compliance.
CIN U24232PB1995PTC016354 Incorporated 05 May 1995 ROC Chandigarh HQ Punjab, India
Active Private Limited Company pharma MSME
Revenue · FY 2024
₹10.3 Cr
▲ 92% YoY
Net profit · FY 2024
₹6.58 Lakh
Net margin 0.6%
EBITDA · FY 2024
₹71.59 Lakh
EBITDA margin 7%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹9.08 Cr
Satisfied ₹15.33 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
2
Provident fund records

About Banson Pharmaceuticals Private Limited

Data last updated:

Banson Pharmaceuticals Private Limited is a private limited company based in Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 May 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB1995PTC016354. Its GSTIN is 03AAACB7134R1ZJ (Punjab).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Santosh Kumar Bansal and Anish Kumar Bansal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # Dewana Streetnabha Distt Patiala, Punjab, India – 147201.

As per the financials filed for FY 2024, the company reported a revenue of ₹10.3 Cr, a growth of 92% compared to the previous year. For the same year it recorded a net profit of ₹6.58 Lakh (net margin 0.6%) and EBITDA of ₹71.59 Lakh (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 19% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Banson Pharmaceuticals Pvt Ltd. As per MCA filings, the company has open charges of ₹9.08 Cr and satisfied charges of ₹15.33 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 1 case is pending.

Banson Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-PB-17-0006788). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bansonpharma.com.

Company details

CIN U24232PB1995PTC016354
Registration Number 016354
Incorporation Date 05 May 1995
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-PB-17-0006788

Recognitions & Rankings of Banson Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-PB-17-0006788

Contact details

Banson Pharmaceuticals Private Limited's registered office is in Punjab. Its website is bansonpharma.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    # Dewana Streetnabha Distt Patiala, Punjab, India – 147201
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Banson Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Banson Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Banson Pharmaceuticals operates one associated brand: Banson Pharmaceuticals Pvt Ltd. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of high-quality pharmaceutical tablets, capsules, and formulations in India.bansonpharma.com

Business activity

The main business activity of Banson Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Banson Pharmaceuticals Private Limited, buy the company report.

Financials of Banson Pharmaceuticals Private Limited

FY 2025 filings available

Banson Pharmaceuticals Private Limited reported revenue of ₹10.3 Cr (up 92% YoY) for FY 2024.

Revenue · FY 2024
₹10.3 Cr ▲ 92%
Net profit · FY 2024
₹6.58 Lakh margin 0.6%
EBITDA · FY 2024
₹71.59 Lakh margin 7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 92%
3 years · compounded
▲ 32%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 24%
5 years · compounded
▲ 11%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 92% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹71.59 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.58 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin7%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Banson Pharmaceuticals Private Limited, buy the company report.

Board of directors of Banson Pharmaceuticals Private Limited

Banson Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Santosh Kumar BansalDirector05 May 199531 Years 6 MonthsCurrent
Anish Kumar BansalDirector02 Apr 20224 Years 7 MonthsCurrent

Peer comparison

Banson Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Oasis Pharma and Phytomolecules Private Limited₹10.36 Cr (FY 2025)48.0%Chandigarh, India
Essenzaa Nutrition Private Limited₹10.33 Cr (FY 2024)-5.0%Mumbai, Maharashtra, India
Banson Pharmaceuticals Private Limitedthis company₹10.3 Cr (FY 2024)₹6.58 Lakh0.6%92.0%2Punjab, India
Oziel Pharmaceuticals Private Limited₹10.29 Cr (FY 2025)14.0%Noida, Uttar Pradesh, India

To see the full peer comparison of Banson Pharmaceuticals Private Limited, buy the company report.

Auditor

Banson Pharmaceuticals Private Limited is audited by B.S.GOYAL & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
B.S.GOYAL & COFY 2022005076N

Shareholding

The shareholding of Banson Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Banson Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹9.08 Cr
Satisfied charges
₹15.33 Cr
Breakdown by lending institutions
Canara Bank₹9.04 Cr
Hdfc Bank Limited₹0.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Sep 2025101167333Canara Bank₹1 CrOpen
18 Sep 2025101167336Canara Bank₹9.01 LakhOpen
18 Sep 2025101167348Canara Bank₹19.4 LakhOpen
18 Sep 2025101167356Canara Bank₹6.75 CrOpen
18 Sep 2025101167617Canara Bank₹1.01 CrOpen

To see the full charge records of Banson Pharmaceuticals Private Limited, buy the company report.

Total charge records: 18 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Banson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Banson Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of May 2026.

Employee count
2
Employee growth
-33.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-272
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16

To see the full employee and EPFO history of Banson Pharmaceuticals Private Limited, buy the company report.

GST

Banson Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
03AAACB7134R1ZJPunjabActive01 Jul 2017

To see the full GST registrations and return filing status of Banson Pharmaceuticals Private Limited, buy the company report.

Recent activity

Banson Pharmaceuticals Private Limited has 8 board changes on record since 1995: 5 appointments and 3 cessations. The latest: Anish Kumar Bansal was appointed as Director on 02 Apr 2022.

Charges
A charge registered on 27 Mar 2025 via Charge ID 101072297 with Axis Bank Limited was fully satisfied on 13 Nov 2025.
Charges
A charge registered on 19 Jan 2024 via Charge ID 100854385 with Axis Bank Limited was fully satisfied on 13 Nov 2025.
Charges
A charge registered on 19 Jan 2024 via Charge ID 100854383 with Axis Bank Limited was fully satisfied on 13 Nov 2025.
Charges
A charge registered on 17 Apr 2023 via Charge ID 100715441 with Axis Bank Limited was fully satisfied on 13 Nov 2025.
Charges
A charge registered on 23 Feb 2023 via Charge ID 100681248 with Axis Bank Limited was fully satisfied on 13 Nov 2025.
AGM
Banson Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 1.00 Cr with Charge ID 101167333 was registered on 18 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 0.09 Cr with Charge ID 101167336 was registered on 18 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 0.19 Cr with Charge ID 101167348 was registered on 18 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 6.75 Cr with Charge ID 101167356 was registered on 18 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 1.01 Cr with Charge ID 101167617 was registered on 18 Sep 2025.
Filing
Banson Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.

32 earlier events are in the company report.

Frequently asked questions

Banson Pharmaceuticals is an active private limited company based in Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 May 1995 (31+ years old) and is registered under CIN U24232PB1995PTC016354.

Banson Pharmaceuticals has 2 current directors:

The latest financial statements of Banson Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Banson Pharmaceuticals is 03AAACB7134R1ZJ, registered in Punjab.

The CIN (Corporate Identification Number) of Banson Pharmaceuticals is U24232PB1995PTC016354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Banson Pharmaceuticals has 20 court cases on record: 7 filed by the company and 13 filed against it. 1 is pending. Most are in the district courts.

Banson Pharmaceuticals was incorporated on 05 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Banson Pharmaceuticals by revenue are Oasis Pharma and Phytomolecules Private Limited, Essenzaa Nutrition Private Limited, Oziel Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anish Kumar Bansal was appointed as Director on 02 Apr 2022. Kiran Bansal ceased to be Director on 02 Apr 2022. Rajesh Kumar Bansal ceased to be Director on 06 Jun 2009. Banson Pharmaceuticals has 8 board changes on record in total.

Yes, Banson Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-PB-17-0006788).

Banson Pharmaceuticals can be reached through the website bansonpharma.com. Its registered office is in Punjab, India.